Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality

BACKGROUND: The economic costs of treating patients with metastatic breast cancer have been examined in several studies, but available estimates of economic burden are at least a decade old. In this study, we characterize healthcare utilization and costs in the US among women with metastatic breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Vera-Llonch, Montserrat, Weycker, Derek, Glass, Andrew, Gao, Sue, Borker, Rohit, Qin, Angie, Oster, Gerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141771/
https://www.ncbi.nlm.nih.gov/pubmed/21676243
http://dx.doi.org/10.1186/1471-2407-11-250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141771/
https://www.ncbi.nlm.nih.gov/pubmed/21676243
http://dx.doi.org/10.1186/1471-2407-11-250

Ejemplares similares